The Microbiome-Metabolism Axis: Using Microbiome Science to Support Insulin Sensitivity, GLP-1, and Satiety
Speakers
Christina O’Connor, RD
Sign up for Academy to watch
Gain access to evolving research into evidence-based education that supports streamlined whole person care.
About this webinar
The gut microbiome plays a pivotal role in regulating key metabolic pathways—from insulin sensitivity to appetite control and satiety. With the rise of glucagon-like peptide-1 (GLP-1) therapies and a growing focus on metabolic health, understanding the microbiome’s influence on these processes has never been more important for clinical practice.
In this webinar, we’ll explore the emerging science of the microbiome-metabolism axis and its impact on glucose regulation, GLP-1 secretion, and satiety signaling. Attendees will gain practical insights into how microbiome-targeted interventions can complement existing protocols to improve patient outcomes.
Key takeaways
- Current research on the microbiome’s role in metabolic health and insulin sensitivity
- Mechanisms linking gut bacteria to GLP-1 secretion and satiety regulation
- Clinical strategies for integrating microbiome science into patient protocols
- How supplements and nutrition can be leveraged to support sustainable metabolic outcomes
